Table 1.
Descriptive characteristics of patients with UES of type 1 and type 2.
| Characteristics | Type 1 (nanophthalmic eye) n1 = 31 patients, n2 = 62 eyes | Type 2 (non-nanophthalmic eye) n1 =35; n2 = 44 eyes |
|---|---|---|
| Age (yes) | ||
| Mean | 35.86 ± 12.22 | 44.68 ± 8.18 |
| Median (range) | 31 (26–62) | 43 (32–62) |
| Sex, No. (%) | ||
| Female (%) | 42 (13/31) | 57 (20/35) |
| Male (%) | 58 (18/31) | 43 (15/35) |
| Laterality | 100% | 26 (9/35) |
| Right eye (%) | / | 40 (21/52) |
| Left eye (%) | / | 60 (31/52) |
| Axial length (mm) | ||
| Mean | 15.83 ± 1.45 | 23.45 ± 1.68 |
| Median (range) | 15.16 (13.85–18.03) | 24.03 (21.4–26.20) |
| Average refractive error (D) | +12.6 | <1.00 |
| Closed angle glaucoma (%) | 97 (60/62) | None |
| Systemic symptoms (n, %) | None | polyarteritis nodosa (1, 2.8%), psoriasis (2, 5.7%), demyelinating disease (1, 2.8%), rheumatoid arthritis (2, 5.7%), Sjogren Syndrome (1, 2.8%), chronic dermatitis (1, 2.8%), vasculitis (2, 5.7%), facial nevus flammeus (port-wine stain) (1, 2.8%) |
| Episcleral vessel dilation (%) | None | 81.8% (36/44) |
| Recurrences during follow-up (%) | 6 (4/62) | None |
UES, uveal effusion syndrome; yes, years; D, diopter.